Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

22 Jul 2014
Price Change (% chg)

$0.39 (+1.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENTA.OQ


Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis... (more)


Beta: --
Market Cap (Mil.): $717.60
Shares Outstanding (Mil.): 18.54
Dividend: --
Yield (%): --


  ENTA.OQ Industry Sector
P/E (TTM): -- 102.18 35.85
EPS (TTM): -0.78 -- --
ROI: -17.06 -0.10 18.25
ROE: -12.74 -0.88 19.12
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Validea
Provider: Ford Investor Services, Inc.
Provider: Zacks Investment Research Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks